Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Understanding when to start your retirement plan is crucial for financial security. This guide helps you identify the best time to begin planning.
25,768 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Lucid shares rebound for a second day after the CEO refutes bankruptcy and take-private rumors, with investors eyeing...
President Donald Trump announces a sweeping 10% global tariff on imports, seeking to salvage a faltering trade agenda...
FIFA President Gianni Infantino defended Mexico’s readiness as violence roils the country near the World Cup. This pi...
Eos Energy Enterprises plunged after reporting a Q4 miss and full-year shortfall, erasing over $1B in market value. T...
Regulators signal a softer approach while a Trump-linked venture secures $75 million from Justin Sun, fueling specula...
Oil surged past the $100 mark again on March 12, 2026, after the U.S. signaled limits to protecting the Strait of Hor...
Amazon launches 1-hour and 3-hour delivery across dozens of U.S. markets, delivering faster options for groceries and...
A Manhattan class-action accuses Gemini of misrepresenting its growth plan during its September IPO. Shares have fall...
Ford’s global footprint is narrowing as European and Chinese demand falters, leaving the US as the main growth engine...
A wave of weaker confidence is reshaping housing activity, even as the job market holds steady. This guide breaks dow...
Rising internal strife and political pressure push the FDA toward leadership change, with markets watching how the ag...